Edward Benz, Jr., was named president of the Dana-Farber Cancer Institute in the summer of 2000, and one of the things he’s had to think about since then has been maintaining the center’s edge in genomics. Formerly a department chair at Johns Hopkins University School of Medicine, Benz took some time to talk with GT’s Meredith Salisbury about why it’s important for Dana-Farber to be in the field — and its plan for a new center for genomics research.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.